Clinical molecular imaging

Journal of the American College of Radiology

Volumn 1, Issue 1 SUPPL., 2004, Pages 4-23

  Miller, Janet C ^a   Thrall, James H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Molecular imaging; Molecular probes; MRI; Optical; Optical beacons; PET; Review; Smart probes; SPECT; Tutorial; Ultrasound

Indexed keywords

ALTROPANE I 131; ANNEXIN TC 99M; CASPASE 3; CATHEPSIN B; CATHEPSIN D; CATHEPSIN K; CONTRAST MEDIUM; CROSS LINKED IRON OXIDE TAT PEPTIDE; DOXORUBICIN; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GELATINASE A; INDIUM 111; IODINE 123; IODINE 131; MATRIX METALLOPROTEINASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ENDOGLIN ANTIBODY IN 111; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; PACLITAXEL; PALMITIC ACID C 11; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; THROMBIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ALZHEIMER DISEASE; ANGIOGENESIS; BONE DISEASE; BREAST CANCER; CANCER; CANCER THERAPY; CLINICAL TRIAL; COLON CANCER; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTERMETHOD COMPARISON; LUNG CANCER; LYMPH NODE METASTASIS; MOLECULAR IMAGING; MOLECULAR PROBE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; THROMBUS; TUMOR DIAGNOSIS;

EID: 84928096591     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1546-1440(03)00025-5     Document Type: Article

References (77)

1. Weissleder R. Molecular imaging exploring the next frontier. Radiology. 212:1999;609-614
2. Pomper M. Molecular imaging an overview. Acad Radiol. 8:2001;1141-1153
3. Luker G., Piwnica-Worms D. Beyond the genome molecular imaging in vivo with PET and SPECT. Acad Radiol. 8:2001;4-14
4. Blomley M.J., Cooke J.C., Unger E.C., Monaghan M.J., Cosgrove D.O. Microbubble contrast agents a new era in ultrasound. Br Med J. 322:2001;1222-1225
5. Weissleder R., Mahmood U. Molecular imaging. Radiology. 219:2001;316-333
6. Hustinnx R., Benard F., Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Mol Med. 32:2002;35-46
7. Kwong K., Belliveau J., Chesler D., et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 89:1992;5675-5679
8. Boas D., Gaudette T., Strangman G., Cheng X., Marota J., Mandeville J. The accuracy of near infrared spectroscopy and imaging during focal changes in cerebral hemodynamics. Neuroimage. 13:2001;76-90
9. Jenkins B., Chen Y.C., Rosen B. Investigating the neurochemistry and etiology of neurodegenerative disorders using magnetic resonance spectroscopy. Beal M., Howell N., Bodis-Wollner I. Mitochondria and free radicals in neurodegenerative disease. 1997;423-469 Wiley-Liss, New York
10. Renshaw P.F., Guimaraes A.R., Fava M., et al. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am J Psychiatry. 149:1992;1592-1594
11. Mahmood U., Weissleder R. Some tools for molecular imaging. Acad Radiol. 9:2002;629-631
12. Meade T. Seeing is believing. Acad Radiol. 8:2001;1-3
13. Dayton P.A., Ferrara K.W. Targeted imaging using ultrasound. J Magn Reson Imaging. 16:2002;362-377
14. Luker G.D., Bardill J.P., Prior J.L., Pica C.M., Piwnica-Worms D., Leib D.A. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol. 76:2002;12149-12161
15. Ntziachristos V., Tung C.H., Bremer C., Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nature Med. 8:2002;757-760
16. Mahmood U., Tung C.H., Bogdanov A., Weissleder R. Near infrared optical imaging of protease activity for cancer detection. Radiology. 213:1999;866-870
17. Louie A., Hüber M., Ahrens E., et al. In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotechnol. 18:2000;321-325
18. Allport J., Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol. 29:2001;1237-1246
19. Piwnica-Worms D. Forty-eighth Annual Association of University Radiologists meeting. 2000
20. Weissleder R. Scaling down imaging molecular mapping of cancer in mice. Nat Rev Cancer. 2:2002;1-8
21. Phelps M., Hofman E., Selin C., et al. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med. 19:1978;1311-1319
22. Thrall J., Ziessman H. Nuclear medicine. 2nd ed.:2001;Mosby, St. Louis, Mo
23. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 348:2003;2491-2499
24. Mack M., Balzer J., Straub R., Eichler K., Vogl T. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology. 222:2002;239-244
25. Shen T., Weissleder R., Papisov M., Bogdanov A., Brady T. Monocrystalline iron oxide nanocompounds (MION) physicochemical properties. Magn Reson Med. 29:1993;599-604
26. Weissleder R., Moore A., Mahmood U., et al. In vivo magnetic resonance imaging of transgene expression. Nat Med. 6:2000;351-354
27. Lewin M., Carlesso N., Tung C.H., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 18:2000;410-414
28. Kang H., Josephson L., Petrovsky A., Weissleder R., Bogdanov A. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjugate Chem. 13:2002;122-127
29. Schellenberger E.A., Hogemann D., Josephson L., Weissleder R. Annexin V-CLIO a nanoparticle for detecting apoptosis by MRI. Acad Radiol. 9:(suppl 2):2002;S310-S311
30. Weissleder R., Tung C., Mahmood U., Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 17:1999;375-378
31. Mahmood U., Tung C.H., Tang Y., Weissleder R. Feasibility of in vivo multi-channel optical imaging of gene expression an experimental study in mice. Radiology. 224:2002;446-451
32. Weissleder R., Ntziachristos V. Shedding light onto live molecular targets. Nature Med. 9:2003;123-128
33. Ntziachristos V., Yodh A., Schnall M., Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A. 97:2000;2767-2772
34. Zaheer A., Lenkinski R., Mahmood A., Jones A., Cantley L., Frangioni J. In vivo near infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol. 19:2001;1148-1154
35. Tung C.H., Mahmood U., Bredow S., Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60:2000;4953-4958
36. Bremer C., Tung C.H., Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 7:2001;743-748
37. Chen J., Tung C., Mahmood U., et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 105:2002;2766-2771
38. Forsberg F., Piccoli C., Liu J.B., et al. Hepatic tumor detection MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology. 222:2002;824-829
39. Tardy I., Pochon S., Theraulaz M., Nanjappan P., Schneider M. In vivo ultrasound imaging of thrombi using a target-specific contrast agent. Acad Radiol. 9:(suppl 2):2002;S294-S296
40. Schumann P.A., Christiansen J.P., Quigley R.M., et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 37:2002;587-593
41. Lindner J.R. Detection of inflamed plaques with contrast ultrasound. Am J Cardiol. 90:2002;32L-35L
42. Leong-Poi H., Christiansen J., Klibanov A., Kaul S., Lindner J. Noninvasive Assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(V)-integrins. Circulation. 107:2003;455-460
43. Bar-Shalom R., Valdivia A., Blaufox M. PET imaging in oncology. Semin Nucl Med. 30:2000;150-185
44. Vranjesevic D., Filmont J.E., Meta J., et al. Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med. 43:2002;325-329
45. Samson D.J., Flamm C.R., Pisano E.D., Aronson N. Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy? Acad Radiol. 9:2002;773-783
46. Sigal R., Vogl T., Casselman J., et al. Lymph node metastases from head and neck squamous cell carcinoma MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol. 12:2002;1104-1113
47. Bredow S., Lewin M., Hofman B., Marecos E., Weissleder R. Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin. Eur J Cancer. 36:2000;675-681
48. Rochefort H., Garcia M., Glondu M., et al. Cathepsin D in breast cancer mechanisms and clinical applications, a 1999 overview. Clin Chim Acta. 291:2000;157-170
49. Marten K., Bremer C., Khazaie K., Tung C., Weissleder R. Detection of dysplastic intestinal adenomas using enzyme sensing molecular beacons. Gastroenterology. 122:2002;406-414
50. Rex D.K., Cutler C.S., Lemmel G.T., et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 112:1997;24-28
51. Belhocine T., Steinmetz N., Hustinx R., et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res. 8:2002;2766-2774
52. Gottesman M., Fojo T., Bates S. Multidrug resistance in cancer role of ATP-dependent transporters. Nat Rev Cancer. 2:2002;48-58
53. Ishimaru H., Morikawa M., Iwanaga S., Kaminogo M., Ochi M., Hayashi K. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol. 11:2001;1784-1791
54. Newberg A., Alavi A., Reivich M. Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders. Semin Nucl Med. 32:2002;13-34
55. Swartz B., Mandelkern M. Positron emission tomography the contribution of cognitive activation paradigms to the understanding of the epilepsies. Adv Neurol. 79:1999;901-915
56. Toczek M., Theodore W. Cortical dysplasia and epilepsy functional imaging using single photon computed tomography and positron emission tomography. Neurosurg Clin North Am. 13:2002;71-86
57. Shoghi-Jadid K., Small G.W., Agdeppa E.D., et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 10:2002;24-35
58. Helmuth L. Long-awaited technique spots Alzheimer's toxin. Science. 297:2002;752-753
59. Wang Y., Klunk W., Huang G., Debnath M., Holt D., Mathis C. Synthesis and evaluation of 2-(3′-iodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease. J Mol Neurosci. 19:2002;11-16
60. Fischman A.J., Bonab A.A., Babich J.W., et al. [(11)C, (127)I]Altropane a highly selective ligand for PET imaging of dopamine transporter sites. Synapse. 39:2001;332-342
61. de la Fuente-Fernandez R., Stoessl A.J. Parkinson's disease imaging update. Curr Opin Neurol. 15:2002;477-482
62. Schelbert H. 18F-fluorodeoxyglucose positron emission tomographic imaging of myocardial viability. Semin Nucl Med. 32:2002;60-69
63. Tung C.H., Gerszten R., Jaffer F., Weissleder R. A novel near-infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem. 3:2002;207-211
64. Hartwig W., Carter E., Jimenez R., et al. Chemotactic peptide uptake in acute pancreatitis correlation with tissue accumulation of leukocytes. J Appl Physiol. 87:1999;743-749
65. Babich J., Fischman A. Targeted imaging ofinfection. Adv Drug Deliv Rev. 37:1999;237-252
66. Huub J., Rennen O., Oyen W., Corstens F. Imaging infection/inflammation in the new millennium. Eur J Nucl Med. 28:2001;241-252
67. Jacobs A., Voges J., Reszka R., et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 358:2001;727-729
68. Bogdanov A., Weissleder R. In vivo imaging of gene delivery and expression. Trends Biotechnol. 20:2002;S11-S18
69. Bulte J.W., Duncan I.D., Frank J.A. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab. 22:2002;899-907
70. Bullok K.E., Dyszlewski M., Prior J.L., Pica C.M., Sharma V., Piwnica-Worms D. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug Chem. 13:2002;1226-1237
71. Hillman B., Neiman H. Translating molecular imaging into radiological practice summary of the proceedings of the American College of Radiology Colloquium, April 22-24, 2002. Radiology. 222:2002;19-24
72. Petrella J., Coleman E.E., Doraiswamy P. Neuroimaging and early diagnosis of Alzheimer disease a look to the future. Radiology. 226:2003;315-336
73. Piwnica-Worms D., Chiu M., Budding M., Kronauge J., Kramer R., Croop J. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 53:1993;977-984
74. Fischman A., Bonab A., Babich J., et al. Rapid detection of Parkinson's disease by SPECT with Altropane a selective ligand for dopamine transporters. Synapse. 29:1998;128-141
75. Becker A., Hessenius C., Licha K., et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nature Biotechnol. 19:2001;327-331
76. Yodh A., Chance B. Spectroscopy and imaging with diffusing light. Phys Today. 48:1995;34-40
77. Demitri G., Mehren M., Blanke C., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 347:2002;472-480